Interactive Schedule
Use the search/filter feature below to build a custom schedule. Click on session titles to view descriptions and speaker information.
May 2: Workshops
May 3-4: Conference & Expo
Note: Session dates/times are subject to change. Download the Preliminary Schedule of Events |
Search / Filter
Print
|
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
5:00 PM - 7:00 PM EDT
|
|
|
2022050417:0019:00 000 | WED, MAY 4 | |||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
2:30 PM - 3:15 PM EDT
|
Hygroscopicity Classification of Pharmaceutical Ingredients and Impact on Supply Chain
Speaker(s): Mary Chaves, Amgen, Inc
|
|
2022050414:3015:15 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
9:45 AM - 10:30 AM EDT
|
Impact and Far Reaching Consequences of European Microplastics Regulations on Excipients and Medicinal Products
Speaker(s): Meera Raghuram, IPEC-Americas
|
|
2022050309:4510:30 001 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
1:50 PM - 2:10 PM EDT
|
Improved Supply Chain Security for Distributors of Closed-Pack Pharmaceutical Excipients
Speaker(s): Charlotte McIlvaine, IPEC-Americas / Univar Solutions
|
|
2022050413:5014:10 001 | WED, MAY 4 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
1:00 PM - 1:45 PM EDT
|
Supply Chain Security and its Relationship to Pharmaceutical Quality
Speaker(s): James Fries, RX-360
|
|
2022050413:0013:45 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
9:30 AM - 10:15 AM EDT
|
Animal Health Perspectives on Excipients
Speaker(s): Shane Gassman, Generic Animal Drug Alliance / Dechra Development LLC Courtney Arumugam, Generic Animal Drug Alliance / Piedmont Animal Heatlh
|
|
2022050409:3010:15 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
2:15 PM - 3:00 PM EDT
|
Role of Excipient Properties on Content Uniformity for Batch and Continuous Mixing
Speaker(s): Maarten Jaspers, DFE Pharma GmbH & Co. KG
|
|
2022050314:1515:00 001 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Monday, May 02, 2022 |
Monday, May 02, 2022
5:00 PM - 7:00 PM EDT
|
|
|
2022050217:0019:00 000 | MON, MAY 2 | |||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
5:30 PM - 9:30 PM EDT
|
|
|
2022050317:3021:30 000 | TUE, MAY 3 | |||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
3:30 PM - 4:30 PM EDT
|
The Future of Pharmaceutical Supply Chain
Speaker(s): Lee Spach, Biogen Devon Mahoney, Department of Justice, Antitrust Division Andrew Mast, U.S. Department of Justice, Antitrust Division
|
|
2022050415:3016:30 000 | WED, MAY 4 |
2DF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
8:00 AM - 9:00 AM EDT
|
The Critical Impact of Excipients on the Physicochemical and Structural Characteristics of Topical Drug Products
Speaker(s): Sam Raney, Center for Drug Evaluation and Research Office of Generic Drugs U.S. Food and Drug Administration
|
|
2022050308:0009:00 001 | TUE, MAY 3 |
31F6417C-1F5D-EC11-80F5-900EDE4142F9 2DF6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
4:30 PM - 5:00 PM EDT
|
|
|
2022050416:3017:00 000 | WED, MAY 4 |
11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
3:30 PM - 4:30 PM EDT
|
|
|
2022050315:3016:30 000 | TUE, MAY 3 |
2DF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
10:45 AM - 11:45 AM EDT
|
Novel Excipient Discussion Panel
Speaker(s): Catherine Sheehan, USP Kathy Ulman, IPEC-Americas David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC Robeena Aziz, CDER, FDA Keith Horspool, HorspoolConsulting LLC Tristan McClure-Begley, Defense Advanced Research Projects Agency (DARPA)
|
|
2022050410:4511:45 000 | WED, MAY 4 |
2DF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
8:00 AM - 9:00 AM EDT
|
|
|
2022050408:0009:00 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 0FF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
9:30 AM - 10:15 AM EDT
|
|
|
2022050409:3010:15 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 18F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
9:45 AM - 10:30 AM EDT
|
Medical silicone film former technology enabling novel topical solutions for drug delivery
Speaker(s): Teresa Gorski, DuPont
|
|
2022050309:4510:30 001 | TUE, MAY 3 |
31F6417C-1F5D-EC11-80F5-900EDE4142F9 2BF6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 25F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
1:50 PM - 2:10 PM EDT
|
Challenges in the Development of Novel Lipid Excipients for mRNA Lipid Nanoparticle Drug Products: A COVID-19 Vaccine Case Study
Speaker(s): Roger Pak, Pfizer, Inc
|
|
2022050413:5014:10 001 | WED, MAY 4 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
1:00 PM - 1:45 PM EDT
|
Turning Lipids into Tablets: The High Functionality Solution to Poor API Dissolution
Speaker(s): Anthony Carpanzano, JRS Pharma LP
|
|
2022050413:0013:45 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
1:00 PM - 1:45 PM EDT
|
Where does oxidative stability lie? The Excipients vs The Formulation System
Speaker(s): Jasmine Musakhanian, Gattefossé
|
|
2022050313:0013:45 001 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 44F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
2:15 PM - 3:00 PM EDT
|
Technical Qualification of Alternate Source Excipients in Commercialized Drug Products
Speaker(s): Jennifer Putnam, IPEC-Americas
|
|
2022050314:1515:00 001 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
11:00 AM - 11:45 AM EDT
|
|
|
2022050311:0011:45 001 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3DF6417C-1F5D-EC11-80F5-900EDE4142F9 44F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
2:30 PM - 3:15 PM EDT
|
Improving Excipient Performance Through Particle Engineering
Speaker(s): Kristina Kannheiser, IMCD US Pharma Joe Zeleznik, IPEC-Americas/IMCD US
|
|
2022050414:3015:15 001 | WED, MAY 4 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3DF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Monday, May 02, 2022 |
Monday, May 02, 2022
9:00 AM - 12:00 PM EDT
|
Key new IPEC Papers and Guides: What you need to know!
SOLD OUT
Speaker(s): Kathy Ulman, IPEC-Americas Brian Carlin, Carlin Pharma Consulting LLC Meera Raghuram, IPEC-Americas Priscilla Zawislak, IPEC-Americas Chris Demerlis, CCD Consulting Services Chris Moreton, FinnBrit Consulting Teresa Wegesser, Amgen Jeff Pitt, IFF, Health & Biosciences
|
|
2022050209:0012:00 040 | MON, MAY 2 |
2CF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Monday, May 02, 2022 |
Monday, May 02, 2022
1:00 PM - 4:00 PM EDT
|
An Overview of Excipient Regulations and Requirements in Key Regions and Countries
SOLD OUT
Speaker(s): Kathy Ulman, IPEC-Americas David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC Meera Raghuram, IPEC-Americas Priscilla Zawislak, IPEC-Americas
|
|
2022050213:0016:00 052 | MON, MAY 2 |
2CF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 17F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Monday, May 02, 2022 |
Monday, May 02, 2022
9:00 AM - 12:00 PM EDT
|
Elemental Impurities Implementation Status - Outcomes from PQRI Workshop and Phase 2 Collaborative Study
Speaker(s): Donna Seibert, Perrigo David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC James Harrington, RTI International
|
|
2022050209:0012:00 042 | MON, MAY 2 |
2CF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Monday, May 02, 2022 |
Monday, May 02, 2022
1:00 PM - 4:00 PM EDT
|
Unlock the Benefit/Risk Approach Metrics for Selecting Excipients for Paediatrics
SOLD OUT
Speaker(s): Smita Salunke, UCL School of Pharmacy Anjali Agrawal, Bristol Myers Squibb
|
|
2022050213:0016:00 050 | MON, MAY 2 |
2CF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
4:30 PM - 5:30 PM EDT
|
|
|
2022050316:3017:30 000 | TUE, MAY 3 | |||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
1:20 PM - 1:40 PM EDT
|
Atypical Actives - déjà vu What can be done about new regulatory concerns?
Speaker(s): Priscilla Zawislak, IPEC-Americas
|
|
2022050313:2013:40 001 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
3:00 PM - 3:30 PM EDT
|
Comparative Characterization of Polymers for Ritonavir Amorphous Solid Dispersions
Speaker(s): Ayse Oktay, University of Maryland
|
|
2022050315:0015:30 000 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
10:15 AM - 10:45 AM EDT
|
IPEC Papers and Guides Workshop - Extended Q&A
Speaker(s): Kathy Ulman, IPEC-Americas Brian Carlin, Carlin Pharma Consulting LLC Meera Raghuram, IPEC-Americas Priscilla Zawislak, IPEC-Americas Chris Moreton, FinnBrit Consulting
|
|
2022050410:1510:45 000 | WED, MAY 4 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Wednesday, May 04, 2022 |
Wednesday, May 04, 2022
10:15 AM - 10:45 AM EDT
|
Excipient Regulations and Requirements in Key Regions Workshop - Extended Q&A
Speaker(s): Kathy Ulman, IPEC-Americas David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC Meera Raghuram, IPEC-Americas Priscilla Zawislak, IPEC-Americas
|
|
2022050410:1510:45 000 | WED, MAY 4 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
11:00 AM - 11:20 AM EDT
|
USP’s updates on developing NF LG polymer monograph specifications: Highlights and Key Challenges
Speaker(s): Peng Zhang, US Pharmacopeia
|
|
2022050311:0011:20 001 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 22F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
9:00 AM - 9:45 AM EDT
|
Setting the Course for Novel Excipients – Round Table (Recorded)
Speaker(s): Kathy Ulman, IPEC-Americas David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC Nigel Langley, IPEC-Americas/BASF Corporation Meera Raghuram, IPEC-Americas Priscilla Zawislak, IPEC-Americas
|
|
2022050309:0009:45 000 | TUE, MAY 3 |
2BF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
1:00 PM - 1:20 PM EDT
|
Impact of the EU E171 Ban on Pharmaceuticals - IPEC & Industry Response
Speaker(s): David Schoneker, IPEC-Americas/Black Diamond Regulatory Consulting LLC
|
|
2022050313:0013:20 001 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 14F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 20F6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
10:35 AM - 11:00 AM EDT
|
Role of Excipients in Enhancing the Structural Complexity of Topical Products Containing Microparticles
Speaker(s): Mengmeng Niu, FDA
|
|
2022050310:3511:00 001 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 30F6417C-1F5D-EC11-80F5-900EDE4142F9 11F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
11:25 AM - 11:45 AM EDT
|
Purification of Excipients: How Sustainable CO2 Technology is Changing the Conversation
Speaker(s): Jason Lupoi
|
|
2022050311:2511:45 000 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 0DF6417C-1F5D-EC11-80F5-900EDE4142F9 |
||
Tuesday, May 03, 2022 |
Tuesday, May 03, 2022
1:40 PM - 2:00 PM EDT
|
|
|
2022050313:4014:00 001 | TUE, MAY 3 |
2EF6417C-1F5D-EC11-80F5-900EDE4142F9 31F6417C-1F5D-EC11-80F5-900EDE4142F9 12F6417C-1F5D-EC11-80F5-900EDE4142F9 13F6417C-1F5D-EC11-80F5-900EDE4142F9 15F6417C-1F5D-EC11-80F5-900EDE4142F9 16F6417C-1F5D-EC11-80F5-900EDE4142F9 19F6417C-1F5D-EC11-80F5-900EDE4142F9 1AF6417C-1F5D-EC11-80F5-900EDE4142F9 1BF6417C-1F5D-EC11-80F5-900EDE4142F9 1CF6417C-1F5D-EC11-80F5-900EDE4142F9 1DF6417C-1F5D-EC11-80F5-900EDE4142F9 1EF6417C-1F5D-EC11-80F5-900EDE4142F9 1FF6417C-1F5D-EC11-80F5-900EDE4142F9 10F6417C-1F5D-EC11-80F5-900EDE4142F9 24F6417C-1F5D-EC11-80F5-900EDE4142F9 21F6417C-1F5D-EC11-80F5-900EDE4142F9 27F6417C-1F5D-EC11-80F5-900EDE4142F9 3CF6417C-1F5D-EC11-80F5-900EDE4142F9 43F6417C-1F5D-EC11-80F5-900EDE4142F9 |
See you at the Gaylord Palms Resort & Convention Center in May!